POISONS AND DRUGS (AMENDMENT) ACT 1991 (NO. 4 OF 1991) - SCHEDULE 3
POISONS AND DRUGS (AMENDMENT) ACT 1991 (NO. 4 OF 1991) - SCHEDULE 3
SCHEDULE 3 Section 3
Acepifylline in liquid oral preparations
Adrenaline in preparations containing 1% or less of adrenaline, except in preparations containing 0.02% or less of adrenaline
Aminophylline in liquid oral preparations
Amyl nitrite
Azatadine in oral preparations
Benzoyl peroxide in preparations containing 10% or less of benzoyl peroxide for external human therapeutic use, except when included in Schedule 2
Brompheniramine in oral preparations, except when included in Schedule 2
Buclizine in oral preparations, except when included in Schedule 2
Butyl nitrite
Chlorofluorocarbons alone or in combination with other propellants or refrigerants in liquefied gas form for therapeutic use
Chlorpheniramine in oral preparations, except when included in Schedule 2
Clemastine in oral preparations
Clotrimazole for human use in preparations containing 1% or less of clotrimazole, for treatment of fungal infections of the skin
Codeine when—
(a) compounded with aspirin, paracetamol or any one of their derivatives and no other analgesic substance; and
(b) in divided preparations containing 10 mg or less of codeine per dosage unit with a recommended dose not exceeding 15 mg of codeine;
except when included in Schedule 2
Cyproheptadine in oral preparations
Dexchlorpheniramine in oral preparations, except when included in Schedule 2
Dihydrocodeine when compounded with one or more other therapeutically active substances—
(a) in divided preparations containing 10 mg or less per dosage unit and with a recommended dose not exceeding 15 mg of dihydrocodeine; or
(b) in undivided preparations containing 0.25% or less of dihydrocodeine with a recommended dose not exceeding 15 mg of dihydrocodeine;
except when included in Schedule 2
Dimenhydrinate in oral preparations, except when included in Schedule 2
Dimethindene in oral preparations
Diphenhydramine in oral preparations, except when included in Schedule 2
Diphenylpyraline in oral preparations, except when included in Schedule 2
Dithranol for human therapeutic use
Doxylamine in oral preparations, except when included in Schedule 2
Econazole for human use in preparations containing 1% or less of econazole for treatment of fungal infections of the skin
Ephedrine for internal use, for the relief of respiratory tract conditions only, when compounded with one or more other therapeutically active substances, except—
(a) when included in Schedule 2; or
(b) in liquid preparations containing 10 mg or less of ephedrine per recommended dose
Fenoterol in metered aerosols delivering 200 micrograms or less of fenoterol per metered dose
Flavoxate
Fluorides in dentifrices containing more than 1000 mg/kg of fluoride ion
Fluorocarbons alone or in combination with other propellants or refrigerants in liquefied gas form for therapeutic use
Folic acid for human therapeutic use, except in preparations containing 500 micrograms or less of folic acid per recommended daily dose
Folinic acid for human therapeutic use, except in preparations containing 500 micrograms or less of folinic acid per recommended daily dose
Hydrocortisone (excluding its salts and derivatives other than hydrocortisone acetate) as the only therapeutically active substance in preparations for dermal use containing 0.5% or less of hydrocortisone in packs containing 30 grams or less where the labelling warns against—
(a) contact with the eyes; or
(b) use for acne;
and against use, except on medical advice—
(c) on children under 2 years of age;
(d) for more than 7 days; or
(e) under occlusive dressings
Ibuprofen as the only therapeutically active substance in divided preparations for oral use containing 200 mg or less of ibuprofen per dosage unit in a pack containing 50 or less dosage units and with a recommended daily dose not exceeding 1200 mg of ibuprofen
Idoxuridine in preparations containing 0.5% or less of idoxuridine for dermal use
Insulin
Isoconazole for human use in preparations containing 1% or less of isoconazole, for treatment of fungal infections of the skin
Loperamide in packs of 8 dosage units or less, each dosage unit containing 2 mg or less of loperamide
Mefenamic acid in packs of 30 or less capsules for treatment of spasmodic dysmenorrhoea
Mepyramine in oral preparations
Methdilazine in oral preparations
Miconazole for human use in topical preparations containing 2% or less of miconazole for the treatment of oral candidiasis
Nicotine in chewing tablets containing 2 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking
Nitrofurazone in preparations for dermal use containing 0.2% or less of nitrofurazone
Nystatin in preparations for topical use for treatment of candidal infections only
Octyl nitrite
Pheniramine in oral preparations, except when included in Schedule 2
Phenylpropanolamine in preparations containing 25 mg or less per recommended dose of phenylpropanolamine when labelled only for the relief of coughs or colds
Phenyltoloxamine in oral preparations
Podophyllotoxin for external human therapeutic use in preparations containing 4% or less of podophyllotoxin, except when included in Schedule 2
Podophyllum resin (podophyllin) for external human therapeutic use in preparations containing 20% or less of podophyllin, except when included in Schedule 2
Promethazine in oral preparations, except when included in Schedule 2
Pseudoephedrine, except when included in Schedule 2 or 4
Quinine for human internal therapeutic use, except in liquids containing 40 mg/litre or less of quinine
Salbutamol—
(a) in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or
(b) in capsules of dry powder for inhalation delivering 200 micrograms or less of salbutamol per dose
Santonin
Terbutaline in metered aerosols delivering 250 micrograms or less of terbutaline per metered dose
Terfenadine as the only therapeutically active substance in divided preparations for oral use containing 60 mg or less of terfenadine per dosage unit in a pack containing 20 or less dosage units
Thenyldiamine in oral preparations, except when included in Schedule 2
Theophylline in liquid oral preparations
Tioconazole for human use in preparations containing 1% or less of tioconazole for treatment of fungal infections of the skin
Tretinoin for external human therapeutic use
Trimeprazine—
(a) in solid oral preparations; or
(b) in liquid oral preparations containing 10 mg or less of trimeprazine per 5 ml;
except when included in Schedule 2
Triprolidine in oral preparations, except when included in Schedule 2